Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Fund Manager results
Tips from these results
Recent Share tips:
- Sell Proteome Sciences (PRM) by Steve Moore in ShareProphets
- Sell Thruvision Group (THRU) by Steve Moore in ShareProphets
- Underperform British American Tobacco (BATS) by RBC Capital
- Buy Unilever (ULVR) by DZ Bank
- Add Aviva (AV.) by Simon Watkins in The Motley Fool
- Buy BT Group (BT.A) by Simon Watkins in The Motley Fool
- Underperform Unilever (ULVR) by RBC Capital
- Hold Rio Tinto (RIO) by LBBW
- Hold Aviva (AV.) by Kepler Cheuvreux
- Hold Admiral Group (ADM) by Kepler Cheuvreux
- Reduce Legal & General Group (LGEN) by Kepler Cheuvreux
- Hold Victrex plc (VCT) by Berenberg
- Buy Applied Nutrition (APN) by Berenberg
- Outperform Moonpig Group (MOON) by RBC Capital
- Buy Ocado Group (OCDO) by Deutsche Bank
- Buy Abrdn (ABDN) by Deutsche Bank
- Buy Relx plc (REL) by Deutsche Bank
- Sell ITM Power (ITM) by Goldman Sachs
- Underweight Kingfisher (KGF) by Barclays
- Buy Barclays (BARC) by UBS
Allergy Therapeutics (AGY) Share Price
Health Care Sector
NOTE: This is based on 23 open tips for Allergy Therapeutics (AGY)
| Latest Bid : 10.50p | Latest Ask : 11.00p |
| High Today : 11.00p | Low Today : 10.16p |
| This Years High : 11.00p | This Years Low : 5.25p |
| Volume : 1,213,185 | MKT Cap : £509.96M |
| Trading Velocity : Premium Only | Activity Score : Premium Only |
| Consensus Score : Premium Only | Momentum Score : Premium Only |
Allergy Therapeutics (AGY) Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.Allergy Therapeutics (AGY) Latest Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-27 14:40:00 27/08/2024 | -167.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -365.22% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -345.83% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -167.50% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 50.00% |
Allergy Therapeutics (AGY) Active Short Positions
| Fund Manager | Position | Date | ||
|---|---|---|---|---|
| No active short positions | ||||
| Latest Bid : 10.50p | Latest Ask : 11.00p |
| High Today : 11.00p | Low Today : 10.16p |
| This Years High : 11.00p | This Years Low : 5.25p |
| Volume : 1,213,185 | MKT Cap : £509.96M |
Allergy Therapeutics Overview
We are a market leading, pioneering immunology business with specialist experience in the research and development of allergy treatments. We believe that transformational outcomes for patients are achieved by directly treating the cause, rather than just managing symptoms. Our vaccines are aluminium free. Driving convenience; our ultra-short course treatments make life easier and increase adherence.NOTE: This description is in part generated by ChatGPT and not an endorsement by or the opinion of Stockomendation Ltd.
Latest Allergy Therapeutics Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| Sell | Steve Moore | Premium Only | 2024-08-27 14:40:00 27/08/2024 | -167.50% |
| Avoid | Steve Moore | Premium Only | 2024-02-14 13:40:00 14/02/2024 | -365.22% |
| Avoid | Steve Moore | Premium Only | 2023-08-10 11:35:00 10/08/2023 | -345.83% |
| Avoid | Steve Moore | Premium Only | 2022-12-29 10:45:00 29/12/2022 | -167.50% |
| Avoid | Steve Moore | Premium Only | 2022-07-15 16:05:00 15/07/2022 | 50.00% |